Astrana Health Inc (ASTH)
37.19
-0.74
(-1.95%)
USD |
NASDAQ |
Apr 30, 16:00
37.19
0.00 (0.00%)
After-Hours: 20:00
Astrana Health Enterprise Value: 1.479B for April 29, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 29, 2024 | 1.479B |
| April 26, 2024 | 1.425B |
| April 25, 2024 | 1.418B |
| April 24, 2024 | 1.438B |
| April 23, 2024 | 1.459B |
| April 22, 2024 | 1.457B |
| April 19, 2024 | 1.448B |
| April 18, 2024 | 1.442B |
| April 17, 2024 | 1.456B |
| April 16, 2024 | 1.478B |
| April 15, 2024 | 1.534B |
| April 12, 2024 | 1.605B |
| April 11, 2024 | 1.627B |
| April 10, 2024 | 1.624B |
| April 09, 2024 | 1.687B |
| April 08, 2024 | 1.671B |
| April 05, 2024 | 1.651B |
| April 04, 2024 | 1.635B |
| April 03, 2024 | 1.666B |
| April 02, 2024 | 1.665B |
| April 01, 2024 | 1.664B |
| March 28, 2024 | 1.661B |
| March 27, 2024 | 1.622B |
| March 26, 2024 | 1.550B |
| March 25, 2024 | 1.540B |
| Date | Value |
|---|---|
| March 22, 2024 | 1.557B |
| March 21, 2024 | 1.614B |
| March 20, 2024 | 1.642B |
| March 19, 2024 | 1.571B |
| March 18, 2024 | 1.553B |
| March 15, 2024 | 1.567B |
| March 14, 2024 | 1.576B |
| March 13, 2024 | 1.617B |
| March 12, 2024 | 1.664B |
| March 11, 2024 | 1.671B |
| March 08, 2024 | 1.784B |
| March 07, 2024 | 1.783B |
| March 06, 2024 | 1.744B |
| March 05, 2024 | 1.717B |
| March 04, 2024 | 1.750B |
| March 01, 2024 | 1.732B |
| February 29, 2024 | 1.798B |
| February 28, 2024 | 1.741B |
| February 27, 2024 | 1.731B |
| February 26, 2024 | 1.697B |
| February 23, 2024 | 1.609B |
| February 22, 2024 | 1.648B |
| February 21, 2024 | 1.652B |
| February 20, 2024 | 1.676B |
| February 16, 2024 | 1.639B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
529.00M
Minimum
Mar 16 2020
5.276B
Maximum
Nov 16 2021
1.560B
Average
1.458B
Median
Enterprise Value Benchmarks
| American Shared Hospital Services | 28.12M |
| Novo Integrated Sciences Inc | 15.20M |
| Cryo-Cell International Inc | 77.55M |
| P3 Health Partners Inc | 419.42M |
| Biote Corp | 215.19M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 12.36M |
| Revenue (Quarterly) | 353.04M |
| Total Expenses (Quarterly) | 356.91M |
| EPS Diluted (Quarterly) | 0.26 |
| Gross Profit Margin (Quarterly) | 11.04% |
| Profit Margin (Quarterly) | 3.50% |
| Earnings Yield | 3.47% |
| Operating Earnings Yield | 4.85% |
| Normalized Earnings Yield | 3.621 |